RSV Vaccine Modelling

Projections of the population-level impact of vaccination against respiratory syncytial virus (RSV) using transmission dynamic models. This a GSK contracted study to inform vaccine design and implementation and is collaborative with MAEMOD at the Mahidol-Oxford Research Unit (MORU), WT Major Overseas Programme in Bangkok, Thailand. A confidentiality agreement prevents saying more

Funding: GSK Vaccines and Biologicals

Collaborators: Tim Kinyanjui, Wirichada Pan-Ngum, Lisa White,Thierry Van Effelterre, Sylvia Taylor